Pharma & Healthcare
Global Japanese Encephalitis Virus Vaccine Market Research Report 2025
- Sep 09, 25
- ID: 497265
- Pages: 71
- Figures: 70
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Virus Vaccine.
The Japanese Encephalitis Virus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Japanese Encephalitis Virus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Japanese Encephalitis Virus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Research Foundation for Microbial Diseases of Osaka University
Valneva Austria GmbH
Chengdu Institute
Liaoning Dacheng
Wuhan Institute
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Japanese Encephalitis Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Japanese Encephalitis Virus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Virus Vaccine.
The Japanese Encephalitis Virus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Japanese Encephalitis Virus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Japanese Encephalitis Virus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Research Foundation for Microbial Diseases of Osaka University
Valneva Austria GmbH
Chengdu Institute
Liaoning Dacheng
Wuhan Institute
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Japanese Encephalitis Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Japanese Encephalitis Virus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Japanese Encephalitis Virus Vaccine Market Overview
1.1 Product Definition
1.2 Japanese Encephalitis Virus Vaccine by Type
1.2.1 Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Japanese Encephalitis Virus Vaccine by Application
1.3.1 Global Japanese Encephalitis Virus Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Japanese Encephalitis Virus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Japanese Encephalitis Virus Vaccine Revenue 2020-2031
1.4.2 Global Japanese Encephalitis Virus Vaccine Sales 2020-2031
1.4.3 Global Japanese Encephalitis Virus Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Japanese Encephalitis Virus Vaccine Market Competition by Manufacturers
2.1 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Japanese Encephalitis Virus Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Japanese Encephalitis Virus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Date of Enter into This Industry
2.8 Global Japanese Encephalitis Virus Vaccine Market Competitive Situation and Trends
2.8.1 Global Japanese Encephalitis Virus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Japanese Encephalitis Virus Vaccine Players Market Share by Revenue
2.8.3 Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Japanese Encephalitis Virus Vaccine Market Scenario by Region
3.1 Global Japanese Encephalitis Virus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2020-2031
3.2.1 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2020-2025
3.2.2 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2026-2031
3.3 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2020-2031
3.3.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2020-2025
3.3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2026-2031
3.4 North America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.4.1 North America Japanese Encephalitis Virus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Japanese Encephalitis Virus Vaccine Sales by Country (2020-2031)
3.4.3 North America Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.5.1 Europe Japanese Encephalitis Virus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2020-2031)
3.5.3 Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Japanese Encephalitis Virus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Japanese Encephalitis Virus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2020-2031)
4.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2020-2025)
4.1.2 Global Japanese Encephalitis Virus Vaccine Sales by Type (2026-2031)
4.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2020-2031)
4.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2020-2025)
4.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2026-2031)
4.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Japanese Encephalitis Virus Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2020-2031)
5.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2020-2025)
5.1.2 Global Japanese Encephalitis Virus Vaccine Sales by Application (2026-2031)
5.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2020-2031)
5.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2020-2025)
5.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2026-2031)
5.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Japanese Encephalitis Virus Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Research Foundation for Microbial Diseases of Osaka University
6.1.1 Research Foundation for Microbial Diseases of Osaka University Company Information
6.1.2 Research Foundation for Microbial Diseases of Osaka University Description and Business Overview
6.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Portfolio
6.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments/Updates
6.2 Valneva Austria GmbH
6.2.1 Valneva Austria GmbH Company Information
6.2.2 Valneva Austria GmbH Description and Business Overview
6.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Portfolio
6.2.5 Valneva Austria GmbH Recent Developments/Updates
6.3 Chengdu Institute
6.3.1 Chengdu Institute Company Information
6.3.2 Chengdu Institute Description and Business Overview
6.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Portfolio
6.3.5 Chengdu Institute Recent Developments/Updates
6.4 Liaoning Dacheng
6.4.1 Liaoning Dacheng Company Information
6.4.2 Liaoning Dacheng Description and Business Overview
6.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Portfolio
6.4.5 Liaoning Dacheng Recent Developments/Updates
6.5 Wuhan Institute
6.5.1 Wuhan Institute Company Information
6.5.2 Wuhan Institute Description and Business Overview
6.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Portfolio
6.5.5 Wuhan Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Japanese Encephalitis Virus Vaccine Industry Chain Analysis
7.2 Japanese Encephalitis Virus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Japanese Encephalitis Virus Vaccine Production Mode & Process Analysis
7.4 Japanese Encephalitis Virus Vaccine Sales and Marketing
7.4.1 Japanese Encephalitis Virus Vaccine Sales Channels
7.4.2 Japanese Encephalitis Virus Vaccine Distributors
7.5 Japanese Encephalitis Virus Vaccine Customer Analysis
8 Japanese Encephalitis Virus Vaccine Market Dynamics
8.1 Japanese Encephalitis Virus Vaccine Industry Trends
8.2 Japanese Encephalitis Virus Vaccine Market Drivers
8.3 Japanese Encephalitis Virus Vaccine Market Challenges
8.4 Japanese Encephalitis Virus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Japanese Encephalitis Virus Vaccine by Type
1.2.1 Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Japanese Encephalitis Virus Vaccine by Application
1.3.1 Global Japanese Encephalitis Virus Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Japanese Encephalitis Virus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Japanese Encephalitis Virus Vaccine Revenue 2020-2031
1.4.2 Global Japanese Encephalitis Virus Vaccine Sales 2020-2031
1.4.3 Global Japanese Encephalitis Virus Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Japanese Encephalitis Virus Vaccine Market Competition by Manufacturers
2.1 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Japanese Encephalitis Virus Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Japanese Encephalitis Virus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Date of Enter into This Industry
2.8 Global Japanese Encephalitis Virus Vaccine Market Competitive Situation and Trends
2.8.1 Global Japanese Encephalitis Virus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Japanese Encephalitis Virus Vaccine Players Market Share by Revenue
2.8.3 Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Japanese Encephalitis Virus Vaccine Market Scenario by Region
3.1 Global Japanese Encephalitis Virus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2020-2031
3.2.1 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2020-2025
3.2.2 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2026-2031
3.3 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2020-2031
3.3.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2020-2025
3.3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2026-2031
3.4 North America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.4.1 North America Japanese Encephalitis Virus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Japanese Encephalitis Virus Vaccine Sales by Country (2020-2031)
3.4.3 North America Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.5.1 Europe Japanese Encephalitis Virus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2020-2031)
3.5.3 Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Japanese Encephalitis Virus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Japanese Encephalitis Virus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2020-2031)
4.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2020-2025)
4.1.2 Global Japanese Encephalitis Virus Vaccine Sales by Type (2026-2031)
4.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2020-2031)
4.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2020-2025)
4.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2026-2031)
4.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Japanese Encephalitis Virus Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2020-2031)
5.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2020-2025)
5.1.2 Global Japanese Encephalitis Virus Vaccine Sales by Application (2026-2031)
5.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2020-2031)
5.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2020-2025)
5.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2026-2031)
5.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Japanese Encephalitis Virus Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Research Foundation for Microbial Diseases of Osaka University
6.1.1 Research Foundation for Microbial Diseases of Osaka University Company Information
6.1.2 Research Foundation for Microbial Diseases of Osaka University Description and Business Overview
6.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Portfolio
6.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments/Updates
6.2 Valneva Austria GmbH
6.2.1 Valneva Austria GmbH Company Information
6.2.2 Valneva Austria GmbH Description and Business Overview
6.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Portfolio
6.2.5 Valneva Austria GmbH Recent Developments/Updates
6.3 Chengdu Institute
6.3.1 Chengdu Institute Company Information
6.3.2 Chengdu Institute Description and Business Overview
6.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Portfolio
6.3.5 Chengdu Institute Recent Developments/Updates
6.4 Liaoning Dacheng
6.4.1 Liaoning Dacheng Company Information
6.4.2 Liaoning Dacheng Description and Business Overview
6.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Portfolio
6.4.5 Liaoning Dacheng Recent Developments/Updates
6.5 Wuhan Institute
6.5.1 Wuhan Institute Company Information
6.5.2 Wuhan Institute Description and Business Overview
6.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Portfolio
6.5.5 Wuhan Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Japanese Encephalitis Virus Vaccine Industry Chain Analysis
7.2 Japanese Encephalitis Virus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Japanese Encephalitis Virus Vaccine Production Mode & Process Analysis
7.4 Japanese Encephalitis Virus Vaccine Sales and Marketing
7.4.1 Japanese Encephalitis Virus Vaccine Sales Channels
7.4.2 Japanese Encephalitis Virus Vaccine Distributors
7.5 Japanese Encephalitis Virus Vaccine Customer Analysis
8 Japanese Encephalitis Virus Vaccine Market Dynamics
8.1 Japanese Encephalitis Virus Vaccine Industry Trends
8.2 Japanese Encephalitis Virus Vaccine Market Drivers
8.3 Japanese Encephalitis Virus Vaccine Market Challenges
8.4 Japanese Encephalitis Virus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Japanese Encephalitis Virus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Japanese Encephalitis Virus Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Japanese Encephalitis Virus Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Japanese Encephalitis Virus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Japanese Encephalitis Virus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Japanese Encephalitis Virus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Japanese Encephalitis Virus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Virus Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Japanese Encephalitis Virus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Japanese Encephalitis Virus Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Japanese Encephalitis Virus Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Japanese Encephalitis Virus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Japanese Encephalitis Virus Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Japanese Encephalitis Virus Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Japanese Encephalitis Virus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. Research Foundation for Microbial Diseases of Osaka University Company Information
Table 71. Research Foundation for Microbial Diseases of Osaka University Description and Business Overview
Table 72. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product
Table 74. Research Foundation for Microbial Diseases of Osaka University Recent Developments/Updates
Table 75. Valneva Austria GmbH Company Information
Table 76. Valneva Austria GmbH Description and Business Overview
Table 77. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product
Table 79. Valneva Austria GmbH Recent Developments/Updates
Table 80. Chengdu Institute Company Information
Table 81. Chengdu Institute Description and Business Overview
Table 82. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Chengdu Institute Japanese Encephalitis Virus Vaccine Product
Table 84. Chengdu Institute Recent Developments/Updates
Table 85. Liaoning Dacheng Company Information
Table 86. Liaoning Dacheng Description and Business Overview
Table 87. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product
Table 89. Liaoning Dacheng Recent Developments/Updates
Table 90. Wuhan Institute Company Information
Table 91. Wuhan Institute Description and Business Overview
Table 92. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Wuhan Institute Japanese Encephalitis Virus Vaccine Product
Table 94. Wuhan Institute Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Japanese Encephalitis Virus Vaccine Distributors List
Table 98. Japanese Encephalitis Virus Vaccine Customers List
Table 99. Japanese Encephalitis Virus Vaccine Market Trends
Table 100. Japanese Encephalitis Virus Vaccine Market Drivers
Table 101. Japanese Encephalitis Virus Vaccine Market Challenges
Table 102. Japanese Encephalitis Virus Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Japanese Encephalitis Virus Vaccine
Figure 2. Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Japanese Encephalitis Virus Vaccine Market Share by Type: 2024 & 2031
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Japanese Encephalitis Virus Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Japanese Encephalitis Virus Vaccine Market Share by Application: 2024 & 2031
Figure 8. Public
Figure 9. Private
Figure 10. Global Japanese Encephalitis Virus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Japanese Encephalitis Virus Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Japanese Encephalitis Virus Vaccine Sales (2020-2031) & (K Units)
Figure 13. Global Japanese Encephalitis Virus Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 14. Japanese Encephalitis Virus Vaccine Report Years Considered
Figure 15. Japanese Encephalitis Virus Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Japanese Encephalitis Virus Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Japanese Encephalitis Virus Vaccine Players: Market Share by Revenue in Japanese Encephalitis Virus Vaccine in 2024
Figure 18. Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Japanese Encephalitis Virus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. the United States Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Japanese Encephalitis Virus Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Japanese Encephalitis Virus Vaccine by Type (2020-2031)
Figure 54. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Japanese Encephalitis Virus Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Japanese Encephalitis Virus Vaccine by Application (2020-2031)
Figure 57. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 58. Japanese Encephalitis Virus Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Japanese Encephalitis Virus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Japanese Encephalitis Virus Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Japanese Encephalitis Virus Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Japanese Encephalitis Virus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Japanese Encephalitis Virus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Japanese Encephalitis Virus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Japanese Encephalitis Virus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Virus Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Japanese Encephalitis Virus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Japanese Encephalitis Virus Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Japanese Encephalitis Virus Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Japanese Encephalitis Virus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Japanese Encephalitis Virus Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Japanese Encephalitis Virus Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Japanese Encephalitis Virus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. Research Foundation for Microbial Diseases of Osaka University Company Information
Table 71. Research Foundation for Microbial Diseases of Osaka University Description and Business Overview
Table 72. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product
Table 74. Research Foundation for Microbial Diseases of Osaka University Recent Developments/Updates
Table 75. Valneva Austria GmbH Company Information
Table 76. Valneva Austria GmbH Description and Business Overview
Table 77. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product
Table 79. Valneva Austria GmbH Recent Developments/Updates
Table 80. Chengdu Institute Company Information
Table 81. Chengdu Institute Description and Business Overview
Table 82. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Chengdu Institute Japanese Encephalitis Virus Vaccine Product
Table 84. Chengdu Institute Recent Developments/Updates
Table 85. Liaoning Dacheng Company Information
Table 86. Liaoning Dacheng Description and Business Overview
Table 87. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product
Table 89. Liaoning Dacheng Recent Developments/Updates
Table 90. Wuhan Institute Company Information
Table 91. Wuhan Institute Description and Business Overview
Table 92. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Wuhan Institute Japanese Encephalitis Virus Vaccine Product
Table 94. Wuhan Institute Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Japanese Encephalitis Virus Vaccine Distributors List
Table 98. Japanese Encephalitis Virus Vaccine Customers List
Table 99. Japanese Encephalitis Virus Vaccine Market Trends
Table 100. Japanese Encephalitis Virus Vaccine Market Drivers
Table 101. Japanese Encephalitis Virus Vaccine Market Challenges
Table 102. Japanese Encephalitis Virus Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Japanese Encephalitis Virus Vaccine
Figure 2. Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Japanese Encephalitis Virus Vaccine Market Share by Type: 2024 & 2031
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Japanese Encephalitis Virus Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Japanese Encephalitis Virus Vaccine Market Share by Application: 2024 & 2031
Figure 8. Public
Figure 9. Private
Figure 10. Global Japanese Encephalitis Virus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Japanese Encephalitis Virus Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Japanese Encephalitis Virus Vaccine Sales (2020-2031) & (K Units)
Figure 13. Global Japanese Encephalitis Virus Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 14. Japanese Encephalitis Virus Vaccine Report Years Considered
Figure 15. Japanese Encephalitis Virus Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Japanese Encephalitis Virus Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Japanese Encephalitis Virus Vaccine Players: Market Share by Revenue in Japanese Encephalitis Virus Vaccine in 2024
Figure 18. Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Japanese Encephalitis Virus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. the United States Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Japanese Encephalitis Virus Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Japanese Encephalitis Virus Vaccine by Type (2020-2031)
Figure 54. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Japanese Encephalitis Virus Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Japanese Encephalitis Virus Vaccine by Application (2020-2031)
Figure 57. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 58. Japanese Encephalitis Virus Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232